Navigation Links
Two New Studies Confirm Stethoscopes Pose Significant Risk of Infection That Novel Technology May Soon Address

AseptiScope(TM), Inc. announces it is advancing its innovative medical device to reduce stethoscope contamination that two large U.S. studies, published last week, confirm pose a significant health risk. The two large clinical studies appearing in the American Journal of Infection Control (AJIC) conclude that stethoscopes are often improperly or rarely disinfected. In the AJIC November 6 issue, investigators observed hand and stethoscope hygiene habits of 400 interactions between clinicians and patients in a large urban hospital in Houston, Texas. While disinfection stations and gloves were routinely used in hand hygiene, fewer than 1 in 5 stethoscopes were disinfected, with less than 4% of interactions conforming to CDC guidelines. As published in Friday’s AJIC, investigators observed 426 emergency room patient encounters at a San Diego, California based healthcare system and found stethoscope hygiene occurring in no more than 13% of patient interactions, though not necessarily in compliance with CDC guidelines.

According to investigators, with existing technology limitations, stethoscope hygiene is frequently neglected. “We know that stethoscopes and hands carry similar pathogen contamination levels, and stethoscopes can transfer these pathogens between patients,” said David Boulée, lead investigator in the AJIC study out of Texas. “However, an effective solution for this clinical dilemma, such as safe-to-touch wipes or a no-touch dispenser system for an audiologically transparent single-use barrier, is not readily available.”

In the fast-paced and highly intense emergency setting, investigators from the November 9 San Diego study suggest stethoscope hygiene is about more than just a quick wipe with alcohol. “At each patient encounter, clinicians should be reminded of stethoscope hygiene for hands and stethoscopes, and have access to a rapid, effective method to reduce transference of bacteria and other contaminants during the exam,” said Dr. Punam Chowdhury. “In our study, we observed some clinicians wrapping a glove over the stethoscope in an effort to reduce cross-contamination. This is a clear indication of a problem that needs a solution.”

Scott Mader, CEO of AseptiScope, Inc., a California based medical device company, believes they will soon have a solution to address this problem. “We are preparing to introduce the first touch-free, single use stethoscope barrier dispensing system. The AseptiScope DiskCover(TM) System will provide clinicians a visible, rapid and affordable solution that applies a clean barrier directly to the stethoscope in a few seconds, permitting a timely, clean and effective examination with patients.” The AseptiScope(TM) DiskCover(TM) System is planned for release in 2019.

About AseptiScope, Inc.
AseptiScope is a privately funded San Diego, California based, clinical innovation company, formed in early 2016. The organization is founded and led by clinical innovation experts, leading medical researchers and practicing physicians. The AseptiScope mission is to design, develop, manufacture and commercialize novel solutions that ensure “Infection Protection for Clinician & Patient.” The company will introduce the first true and practical solution for the longstanding challenge of stethoscope contamination in 2019: The AseptiScope DiskCover(TM) System.

Aseptiscope and DiskCover are trademarks of Aseptiscope Inc.

Read the full story at

Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved

Related biology technology :

1. IONpath Shares Comprehensive Studies of Enumeration of Immune Cells in Solid Tumors in Educational Webinar
2. Dharmacon Highlights CRISPRa Tools for Transcriptional Activation Studies
3. Multidisciplinary Association for Psychedelic Studies (MAPS) Selects Montriums eTMF Platform as They Begin Phase 3 Studies of MDMA-assisted Psychotherapy for PTSD
4. Clearwater, FL Periodontist, Dr. Todd Britten Cites Periodontal Studies Urging Patients to Seek Gum Disease Treatment
5. Terumo BCT to Showcase Scaling Cell Therapy Manufacturing Case Studies
6. Lilly Announces Positive Results for Three Phase 3 Studies of Galcanezumab for the Prevention of Episodic and Chronic Migraine
7. KCAS Bioanalytical and Biomarker Services Now Offers Ultra-Sensitive Validated Assay for Nicotine Studies
8. Quorum Review IRB Launches World’s First IRB-Integrated eConsent Solution for Clinical Research Studies
9. Vortex Biosciences Presents Studies at AACR That Demonstrate Use of the VTX-1 System for Isolating and Analyzing Circulating Tumor Cells for Cancer Research
10. Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies
11. Incorporating Safety Pharmacology Endpoints in Toxicology Studies: Transposing the Experience with Biopharmaceuticals Into Small Molecules
Post Your Comments:
(Date:1/30/2019)... , ... January 29, 2019 , ... ... someone is frustrated over something like a tricky math problem on an online ... led by Worcester Polytechnic Institute (WPI) computer science assistant professor Erin Solovey ...
(Date:1/28/2019)... ... 28, 2019 , ... Fragment-based lead discovery (FBLD) involves biophysical ... stage, false positives can be problematic due to high levels of solvents and ... are highly sensitive to detect weak interactions. Nanomed , leading producer of ...
(Date:1/24/2019)... FRANCISCO (PRWEB) , ... January 23, 2019 , ... ... leader in microbial genomics, has awarded microbiome research support in study design, planning, ... (UWI), Faculty of Medical Sciences, St. Augustine Campus in Trinidad led by Dr. ...
(Date:1/20/2019)... ... January 17, 2019 , ... The American Society of Gene & Cell Therapy ... , a new initiative for 2019. Designed by ASGCT committee volunteers in coordination with ... families, and the public on the status and promise of gene and cell therapies. ...
Breaking Biology Technology:
(Date:1/8/2019)... (PRWEB) , ... January 07, 2019 , ... Join industry ... Ridge for a live webinar on Thursday, January 17, 2019 at 1pm ... ongoing management of risk during the clinical trial process. Featured speakers will also present ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... (RWD) and Artificial Intelligence solutions for precision health in oncology and other key ... J.P Morgan’s exclusive meeting of investors, entrepreneurs and executives spanning the entire healthcare ...
(Date:1/4/2019)... FORT WORTH, Texas (PRWEB) , ... January 02, ... ... 2019 catalog. This release is particularly noteworthy, as the life science tools and ... company’s history, it is offering a catalog. The catalog features not just part ...
Breaking Biology News(10 mins):